Glu298Asp polymorphism of the eNOS gene is associated with coronary collateral development

Atherosclerosis

Volumn 198, Issue 2, 2008, Pages 354-359

  Gulec, Sadi ^a   Karabulut, Halil ^a   Ozdemir, Aydan Ongun ^a   Ozdol, Cagdas ^a   Turhan, Sibel ^a   Altin, Timuçin ^a   Tutar, Eralp ^a   Genc, Yasemin ^a   Erol, Çetin ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Coronary collaterals; Diabetes mellitus; Endothelial nitric oxide synthase; Polymorphism

Indexed keywords

DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTERY OCCLUSION; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; ENZYME ACTIVITY; FEMALE; GENE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UNSTABLE ANGINA PECTORIS;

AGED; ALLELES; AMINO ACID SUBSTITUTION; ASPARTIC ACID; CORONARY OCCLUSION; CORONARY STENOSIS; CORONARY VESSELS; DIABETES COMPLICATIONS; FEMALE; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS;

EID: 43949125497     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.037     Document Type: Article

References (33)

1. Cohen M., and Rentrop K.P. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 74 (1986) 469-476
2. Pohl T., Seiler C., Billinger M., et al. Frequency distribution of collateral flow and adverse cardiac ischemic events: a follow-up study in 450 patients with coronary artery disease. J Am Coll Cardiol 38 (2001) 1872-1878
3. Korselman J., van der Graaf Y., de Jaegere P.P.T., and Grobbee D.E. Coronary collaterals, an important and underexposed aspect of coronary artery disease. Circulation 107 (2003) 2507-2511
4. Kilian J.G., Keech A., Adams M.R., and Celermajer D.S. Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis 13 (2002) 155-159
5. Pourati I., Kimmelstiel C., Rand W., and Karas R.H. Statin use is associated with enhanced collateralization of severely diseased coronary arteries. Am Heart J 146 (2003) 876-881
6. Gulec S., Ozdemir A.O., Maradit-Kremers H., et al. Elevated levels of C-reactive protein are associated with impaired coronary collateral development. Eur J Clin Invest 36 (2006) 369-375
7. Prior B.M., Lloyd P.G., Ren J., et al. Arteriogenesis: role of nitric oxide. Endothelium 10 (2003) 207-216
8. Lloyd P.G., Yang T.H., and Terjung R.L. Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am J Physiol Heart Circ Physiol 281 (2001) H2528-H2538
9. Tesauro M., Thompson W.C., Rogliani P., et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 97 (2000) 2832-2835
10. Persu A., Stoenoiu M.S., Messiaen T., et al. Modifier effect of eNOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 11 (2002) 229-241
11. Rentrop K.P., Cohen M., Blanke H., and Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5 (1985) 587-592
12. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 102 (2000) 1193-1209
13. Dodge H.T., Sandler H., Baxley W.A., and Hawley R.R. Usefulness and limitations of radiographic methods for determining left ventricular volume. Am J Cardiol 18 (1966) 10-24
14. Yoshimura M., Yasue H., Nakayama M., et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103 (1998) 65-69
15. Tayebjee M.H., Lip G.Y.H., and Macfadyen R.J. Collateralization and the response to obstruction of epicardial coronary arteries. QJM 97 (2004) 259-272
16. Amano K., Matsubara H., Iba O., et al. Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 41 (2003) 156-162
17. Murohara T., Asahara T., Silver M., et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101 (1998) 2567-2578
18. Unthank J.L., Nixon J.C., and Dalsing M.C. Nitric oxide maintains dilation of immature and mature collaterals in rat hindlimb. J Vasc Res 33 (1996) 471-479
19. Tronc F., Wassef M., Esposito B., et al. Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler Thromb Vasc Biol 16 (1996) 1256-1262
20. Buckwalter J.B., Curti{dotless}s V.C., Vali{dotless}c Z., Ruble S.B., and Clifford P.S. Endogenous vascular remodeling in ischemic skeletal muscle: a role for nitric oxide. J Appl Physiol 94 (2003) 935-940
21. Matsunaga T., Wartlier D.C., Weihrauch D.W., et al. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102 (2000) 3098-3103
22. Lamblin N., Cuilleret F.J., Helbecque N., et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions. BMC Cardiovasc Disord 5 (2005) 27-32
23. Hingorani A.D. Polymorphisms in endothelial nitric oxide synthase and atherogenesis John French Lecture 2000. Atherosclerosis 154 (2000) 521-527
24. McDonald D.M., and Alp N.J. Channon KM: Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics 14 (2004) 831-839
25. Casas J.P., Bautista L.E., Humphries S.E., and Hingorani A.D. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23 028 subjects. Circulation 109 (2004) 1359-1365
26. Savvidou M.D., Vallance P.J., Nicolaides K.H., and Hingorani A.D. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 38 (2001) 1289-1293
27. Leeson C.P., Hingorani A.D., Mullen M.J., et al. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res 90 (2002) 1153-1158
28. Abaci A., Oguzhan A., Kahraman S., et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99 (1999) 2239-2242
29. Kersten J.R., Toller W.G., Tessmer J.P., Pagel P.S., and Wartier D.C. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol 281 (2001) H2097-H2104
30. Laufs U., La Fata V., Plutzky J., and Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA Reductase inhibitors. Circulation 97 (1998) 1129-1135
31. Dincer I., Ongun A., Turhan S., et al. Effect of statin treatment on coronary collateral development in patients with diabetes mellitus. Am J Cardiol 97 (2006) 772-774
32. Marroni A.S., Metzger I.F., Souza-Costa D.C., et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12 (2005) 177-182
33. Awata T., Neda T., Iizuka H., et al. Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. Diabetes Care 27 (2004) 2184-2190